Real Estate - Services
Compare Stocks
5 / 10Stock Comparison
NEN vs WELL vs NHI vs EQR vs AVB
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Residential
REIT - Residential
NEN vs WELL vs NHI vs EQR vs AVB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Residential | REIT - Residential |
| Market Cap | $168M | $151.66B | $3.58B | $24.79B | $25.94B |
| Revenue (TTM) | $89M | $11.63B | $403M | $3.12B | $3.04B |
| Net Income (TTM) | $6M | $1.43B | $148M | $954M | $1.05B |
| Gross Margin | 49.1% | 39.1% | 61.3% | 46.3% | 67.0% |
| Operating Margin | 24.4% | 4.4% | 48.5% | 28.5% | 30.1% |
| Forward P/E | 34.7x | 79.7x | 21.8x | 50.8x | 37.9x |
| Total Debt | $528M | $21.38B | $1.16B | $8.78B | $9.33B |
| Cash & Equiv. | $26.67B | $5.03B | $20M | $56M | $187M |
NEN vs WELL vs NHI vs EQR vs AVB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| New England Realty … (NEN) | 100 | 119.1 | +19.1% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
| National Health Inv… (NHI) | 100 | 133.1 | +33.1% |
| Equity Residential (EQR) | 100 | 109.2 | +9.2% |
| AvalonBay Communiti… (AVB) | 100 | 119.5 | +19.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEN vs WELL vs NHI vs EQR vs AVB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEN is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 7 yrs, beta 0.14, yield 8.0%
- PEG 1.00 vs EQR's 9.98
- Beta 0.14, yield 8.0%, current ratio 4247.47x
- Lower P/E (34.7x vs 37.9x), PEG 1.00 vs 8.09
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs NHI's 60.5%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs EQR's 4.1%
NHI ranks third and is worth considering specifically for quality and efficiency.
- 36.8% margin vs NEN's 6.8%
- 5.4% ROA vs NEN's 1.3%
EQR lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, AVB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs EQR's 4.1% | |
| Value | Lower P/E (34.7x vs 37.9x), PEG 1.00 vs 8.09 | |
| Quality / Margins | 36.8% margin vs NEN's 6.8% | |
| Stability / Safety | Beta 0.13 vs AVB's 0.48, lower leverage | |
| Dividends | 8.0% yield, 7-year raise streak, vs EQR's 4.1% | |
| Momentum (1Y) | +45.8% vs NEN's -21.5% | |
| Efficiency (ROA) | 5.4% ROA vs NEN's 1.3% |
NEN vs WELL vs NHI vs EQR vs AVB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NEN vs WELL vs NHI vs EQR vs AVB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 2 of 6 categories
NEN leads 1 • WELL leads 1 • EQR leads 0 • AVB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 130.4x NEN's $89M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to NEN's 6.8%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $89M | $11.6B | $403M | $3.1B | $3.0B |
| EBITDAEarnings before interest/tax | $45M | $2.8B | $282M | $1.9B | $1.8B |
| Net IncomeAfter-tax profit | $6M | $1.4B | $148M | $954M | $1.1B |
| Free Cash FlowCash after capex | $27M | $2.5B | $226M | $1.3B | $1.5B |
| Gross MarginGross profit ÷ Revenue | +49.1% | +39.1% | +61.3% | +46.3% | +67.0% |
| Operating MarginEBIT ÷ Revenue | +24.4% | +4.4% | +48.5% | +28.5% | +30.1% |
| Net MarginNet income ÷ Revenue | +6.8% | +12.3% | +36.8% | +30.6% | +34.6% |
| FCF MarginFCF ÷ Revenue | +30.7% | +21.9% | +56.1% | +42.7% | +49.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.7% | +40.3% | +29.7% | +2.5% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -133.3% | +22.5% | +10.8% | -64.2% | -40.9% |
Valuation Metrics
NEN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 22.7x trailing earnings, EQR trades at a 85% valuation discount to WELL's 155.7x P/E. Adjusting for growth (PEG ratio), NEN offers better value at 1.00x vs AVB's 5.39x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $168M | $151.7B | $3.6B | $24.8B | $25.9B |
| Enterprise ValueMkt cap + debt − cash | -$26.0B | $168.0B | $4.7B | $33.5B | $35.1B |
| Trailing P/EPrice ÷ TTM EPS | 34.71x | 155.73x | 24.46x | 22.74x | 25.23x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 79.69x | 21.82x | 50.84x | 37.85x |
| PEG RatioP/E ÷ EPS growth rate | 1.00x | — | — | 4.46x | 5.39x |
| EV / EBITDAEnterprise value multiple | -1.12x | 67.37x | 16.96x | 15.66x | 19.20x |
| Price / SalesMarket cap ÷ Revenue | 1.89x | 14.22x | 9.46x | 7.99x | 8.53x |
| Price / BookPrice ÷ Book value/share | — | 3.40x | 2.26x | 2.25x | 2.24x |
| Price / FCFMarket cap ÷ FCF | 0.01x | 53.25x | 16.26x | 19.22x | 18.35x |
Profitability & Efficiency
NHI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVB's 0.79x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs AVB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +3.5% | +9.8% | +8.4% | +8.8% |
| ROA (TTM)Return on assets | +1.3% | +2.3% | +5.4% | +4.6% | +4.8% |
| ROICReturn on invested capital | — | +0.5% | +5.6% | +4.2% | +3.3% |
| ROCEReturn on capital employed | +4.9% | +0.6% | +8.0% | +5.7% | +4.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 0.49x | 0.76x | 0.77x | 0.79x |
| Net DebtTotal debt minus cash | -$26.1B | $16.3B | $1.1B | $8.7B | $9.1B |
| Cash & Equiv.Liquid assets | $26.7B | $5.0B | $20M | $56M | $187M |
| Total DebtShort + long-term debt | $528M | $21.4B | $1.2B | $8.8B | $9.3B |
| Interest CoverageEBIT ÷ Interest expense | 1.17x | 0.26x | 3.45x | 5.58x | 5.07x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $10,776 for EQR. Over the past 12 months, WELL leads with a +45.8% total return vs NEN's -21.5%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs NEN's -0.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.8% | +16.2% | -2.7% | +8.9% | +4.3% |
| 1-Year ReturnPast 12 months | -21.5% | +45.8% | +1.5% | -2.3% | -6.9% |
| 3-Year ReturnCumulative with dividends | -0.4% | +194.0% | +71.1% | +18.0% | +14.8% |
| 5-Year ReturnCumulative with dividends | +26.2% | +211.9% | +29.5% | +7.8% | +13.7% |
| 10-Year ReturnCumulative with dividends | +48.1% | +233.9% | +60.5% | +31.0% | +32.9% |
| CAGR (3Y)Annualised 3-year return | -0.1% | +43.3% | +19.6% | +5.7% | +4.7% |
Risk & Volatility
Evenly matched — WELL and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than AVB's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 98.6% from its 52-week high vs NEN's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 0.13x | -0.08x | 0.38x | 0.48x |
| 52-Week HighHighest price in past year | $79.85 | $219.59 | $90.94 | $71.80 | $209.86 |
| 52-Week LowLowest price in past year | $56.00 | $142.65 | $68.80 | $57.58 | $160.09 |
| % of 52W HighCurrent price vs 52-week peak | +74.8% | +98.6% | +81.2% | +92.1% | +88.8% |
| RSI (14)Momentum oscillator 0–100 | 48.2 | 57.6 | 23.8 | 70.6 | 69.8 |
| Avg Volume (50D)Average daily shares traded | 990 | 2.6M | 330K | 2.3M | 936K |
Analyst Outlook
Evenly matched — NEN and EQR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", NHI as "Hold", EQR as "Hold", AVB as "Hold". Consensus price targets imply 15.6% upside for NHI (target: $85) vs 2.8% for AVB (target: $192). For income investors, NEN offers the higher dividend yield at 8.04% vs WELL's 1.28%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $85.40 | $70.15 | $191.70 |
| # AnalystsCovering analysts | — | 34 | 18 | 46 | 42 |
| Dividend YieldAnnual dividend ÷ price | +8.0% | +1.3% | +4.9% | +4.1% | +3.7% |
| Dividend StreakConsecutive years of raises | 7 | 2 | 1 | 8 | 3 |
| Dividend / ShareAnnual DPS | $4.80 | $2.76 | $3.61 | $2.69 | $6.99 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | 0.0% | 0.0% | +1.1% | +1.9% |
NHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NEN leads in 1 (Valuation Metrics). 2 tied.
NEN vs WELL vs NHI vs EQR vs AVB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEN or WELL or NHI or EQR or AVB a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 4. 1% for Equity Residential (EQR). Equity Residential (EQR) offers the better valuation at 22. 7x trailing P/E (50. 8x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEN or WELL or NHI or EQR or AVB?
On trailing P/E, Equity Residential (EQR) is the cheapest at 22.
7x versus Welltower Inc. at 155. 7x. On forward P/E, National Health Investors, Inc. is actually cheaper at 21. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AvalonBay Communities, Inc. wins at 8. 09x versus Equity Residential's 9. 98x.
03Which is the better long-term investment — NEN or WELL or NHI or EQR or AVB?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to +7. 8% for Equity Residential (EQR). Over 10 years, the gap is even starker: WELL returned +233. 9% versus EQR's +31. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEN or WELL or NHI or EQR or AVB?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus AvalonBay Communities, Inc. 's 0. 48β — meaning AVB is approximately -673% more volatile than NHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 79% for AvalonBay Communities, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEN or WELL or NHI or EQR or AVB?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 4. 1% for Equity Residential (EQR). On earnings-per-share growth, the picture is similar: Equity Residential grew EPS 7. 0% year-over-year, compared to -61. 4% for New England Realty Associates Limited Partnership. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEN or WELL or NHI or EQR or AVB?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 6. 8% for New England Realty Associates Limited Partnership — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AVB leads at 67. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEN or WELL or NHI or EQR or AVB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AvalonBay Communities, Inc. (AVB) is the more undervalued stock at a PEG of 8. 09x versus Equity Residential's 9. 98x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, National Health Investors, Inc. (NHI) trades at 21. 8x forward P/E versus 79. 7x for Welltower Inc. — 57. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 15. 6% to $85. 40.
08Which pays a better dividend — NEN or WELL or NHI or EQR or AVB?
All stocks in this comparison pay dividends.
New England Realty Associates Limited Partnership (NEN) offers the highest yield at 8. 0%, versus 1. 3% for Welltower Inc. (WELL).
09Is NEN or WELL or NHI or EQR or AVB better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +60. 5%, AVB: +32. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEN and WELL and NHI and EQR and AVB?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEN is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock; NHI is a small-cap income-oriented stock; EQR is a mid-cap income-oriented stock; AVB is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.